Viewing nowDaimit Xr Sustained Release Tablet (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

MFDS item code 200702272 · Approved 2007.02.21 · Insurance code 648100320
Treatment of type 2 diabetes mellitus in adults
This medication helps improve blood glucose levels in patients with type 2 diabetes who struggle to achieve adequate control with diet and exercise alone, particularly in overweight adult patients. It can be used alone or in combination with other oral hypoglycemic agents or insulin to enhance blood glucose control effects. This helps patients manage their blood sugar levels more effectively.
The dose should be determined individually based on therapeutic response and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is one 500 mg extended-release metformin hydrochloride tablet once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week. Up to 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum dose of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already being treated with metformin tablets, the initial dose of this preparation should be the same as the daily dose of immediate-release metformin tablets. Switching to this preparation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - During treatment initiation and dose adjustment, fasting blood glucose should be measured to assess response to treatment with this medicine and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, this medicine should be discontinued immediately.
This medication can rarely cause a serious condition called lactic acidosis. Lactic acidosis is a state where there is an abnormally high concentration of lactate in the blood, which can be life-threatening if left untreated. Caution is needed when using this medication together with other diabetes treatments as it may lead to severe hypoglycemia. Patients with moderate to severe renal impairment or those with conditions affecting kidney function such as severe infections, congestive heart failure, or acute myocardial infarction should not use this medication. This medication must be discontinued before exams involving contrast media containing iodine and can only be resumed after confirming normal kidney function post-exam. Patients who have an allergic reaction to any components of this medication or those with type 1 diabetes or a history of lactic acidosis or ketoacidosis should not take this medication. Patients with severe infections, pre- and post-surgery patients, or those with severe malnutrition or liver dysfunction should also avoid or use this medication with caution. During treatment, kidney function should be regularly monitored to prevent drug accumulation and associated risks. This medication may cause gastrointestinal disturbances, vitamin B12 deficiency, taste impairment, etc., particularly gastrointestinal symptoms are common at the beginning of treatment but improve over time. Alcohol consumption can increase the risk of lactic acidosis, so it is advisable to avoid drinking during treatment. If blood glucose control suddenly worsens or if symptoms of hypoglycemia appear, immediate consultation with a medical professional is necessary, and in cases of high risk for hypoglycemia, sugar or glucose should be ingested. During pregnancy, it is essential to maintain proper blood glucose levels for the health of both the fetus and mother; hence, careful monitoring is necessary if this medication is to be used during pregnancy. In breastfeeding, this medication is secreted in breast milk, so a cautious decision should be made regarding breastfeeding and treatment. Elderly patients are at risk of decreased kidney function, so dosage adjustment and regular kidney function monitoring are required. In case of overdose, the risk of lactic acidosis is more significant than hypoglycemia, hence immediate medical attention is necessary. This medication should be swallowed whole without chewing or crushing, and it is normal for the tablet coating to be excreted in the stool. The blood glucose control effect may vary depending on other medications taken concurrently, so it is crucial to inform healthcare providers of any other medications used during treatment. Regular monitoring of blood glucose, kidney function, vitamin B12 levels, etc., during the course of treatment is essential for safe management.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. It is important to maintain a temperature between 1 degree and 30 degrees Celsius. This helps preserve the effectiveness of the medication.
White, double convex-shaped, rectangular sustained release tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.